Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
This suggests that the memory loss in APP+PS1 transgenic mice may model the early memory dysfunction in AD before the degeneration of synapses and neurons.
|
12832546 |
2003 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism.
|
27457810 |
2017 |
Memory Loss
|
0.400 |
AlteredExpression
|
phenotype |
BEFREE |
Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
|
27388605 |
2016 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Autophagy impairment by caspase-1-dependent inflammation mediates memory loss in response to β-Amyloid peptide accumulation.
|
28801921 |
2018 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Three months of treatment of AAV9-GFP-CIP reduced pathologic changes, including τ hyperphosphorylation, (Aβ) deposit, astrocytosis, and microgliosis, which were correlated with the reversal of memory loss and anxiety-like behavior observed in APP/PS1 mice.
|
28420695 |
2017 |
Memory Loss
|
0.400 |
GeneticVariation
|
phenotype |
BEFREE |
An increased amount or mutation(s) in PS1, which alters the stoichiometric balance of the gamma-secretase complex, may be the cause of aberrant or increased processing of APP, resulting in Abeta accumulation leading to loss of memory.
|
19181896 |
2009 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Transgene expression of familial Alzheimer's disease-linked mutants of β-amyloid precursor protein (APP) and presenilin-1 leads to a significant inhibition of neurogenesis, which is potentially linked to age-dependent memory loss.
|
22042871 |
2011 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
The elevation of Rac1 activity not only accelerated 6-hour spatial memory decay in 3-month-old APP/PS1 mice, but also significantly contributed to severe memory loss in aged APP/PS1 mice.
|
31321704 |
2019 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
More importantly, the Pt<sup>II</sup> -PW<sub>11</sub> greatly reduced Aβ deposition and rescued memory loss in APP/PS1 transgenic AD model mice without noticeable cytotoxicity, demonstrating its potential as drugs for AD treatment.
|
31591753 |
2019 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Functionally, removing CX3CR1 in human amyloid precursor protein mice worsened the memory retention in passive avoidance and novel object recognition tests, and their memory loss in the novel object recognition test is associated with high levels of interleukin 6.
|
21771791 |
2011 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
The brain formaldehyde level in APP/PS1-transgenic (n=8) mice at age of 3 months and APP-transgenic (n=8) mice at age of 6 months was increased (0.56 ± 0.02 mM), respectively, as compared with their respective age-matched controls, when these two types of AD-like animals, respectively, started to form Aβ deposits and memory loss obviously.
|
19879019 |
2011 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
31678156 |
2020 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
A significant component of memory loss in APP transgenic mice is apparently caused by soluble A Beta assemblies, but whether and how much of the dementia within individuals afflicted with AD is caused by these A Beta species is unclear.
|
11773429 |
2002 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
The amyloid precursor protein (APP) and its cleavage product Aβ play central roles in synapse and memory loss, and thus are strongly implicated in the pathogenesis of AD.
|
21199446 |
2012 |
Memory Loss
|
0.400 |
AlteredExpression
|
phenotype |
BEFREE |
Treatment of 3xTg-AD mice with flavocoxid reduced: (1) learning and memory loss; (2) the increased eicosanoid production and the phosphorylation level of amyloid precursor protein (APP-pThr668), Aβ 1-42, p-tau (pThr181), pERK, and the activation of the NLRP3 inflammasome; (3) Aβ plaques; and (4) neuronal loss, compared to saline-treated animals.
|
28238167 |
2017 |
Memory Loss
|
0.400 |
AlteredExpression
|
phenotype |
BEFREE |
Somatostatin (SST) blocks the aggregation of Aβ and inflammation whereas reduction of SST levels in the CSF and brain tissue is associated with impaired cognitive function and memory loss.
|
29700775 |
2019 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
APP/PS1 double-transgenic mice treated with 3F5 mAb showed reduced memory loss, cognitive decline, and decreased levels of amyloid deposits in the brain.
|
28662102 |
2017 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Here, we use the J20-APP AD mouse model that displays spatial memory loss as well as reduced slow gamma amplitude and phase-amplitude coupling to theta oscillations phase.
|
31757962 |
2019 |
Memory Loss
|
0.400 |
GeneticVariation
|
phenotype |
BEFREE |
Transgenic mice which carried the mutant form of the beta-amyloid precursor protein gene expressed high concentrations of mutant copy of the gene and exhibited abundant amyloid plaques in the brain and memory loss.
|
9206974 |
1997 |
Memory Loss
|
0.400 |
GeneticVariation
|
phenotype |
BEFREE |
The amyloid hypothesis does not adequately address the pathogenesis of the disease, however, since transgenic mice that express the pathologic mutations of the APP and presenilin-1 (PS1) genes produce amyloid plaques but fail to exhibit neurodegeneration and memory loss observed in AD patients.
|
17981591 |
2008 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.
|
24858312 |
2014 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
[Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
|
27306655 |
2016 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
|
15364477 |
2004 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats.
|
22484447 |
2012 |
Memory Loss
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.
|
18599028 |
2008 |